Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma
- 1 March 2008
- journal article
- case report
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 50 (3) , 699-700
Abstract
Paclitaxel is an antineoplastic agent that is used in the treatment of a variety of solid tumors. Dose-limiting side effects of myelosuppression and peripheral neuropathy are well known. Paclitaxel has minimal penetration of the blood-brain barrier and central nervous system side effects are rare. However, transient encephalopathy following paclitaxel infusion has been described in adults but not in children. We present the case of a 14-year-old female with a recurrent suprasellar germinoma who developed an acute encephalopathy 4-6 hr following paclitaxel infusion.Keywords
This publication has 9 references indexed in Scilit:
- Encéphalopathie aiguë après injection de paclitaxelRevue des Maladies Respiratoires, 2006
- Managing taxane toxicitiesSupportive Care in Cancer, 2003
- Acute transient encephalopathy after paclitaxel infusion: report of three casesAnnals of Oncology, 2002
- Transient encephalopathy after paclitaxel (Taxol) infusionNeurology, 1996
- Plasma alcohol concentrations in patients following paclitaxel infusionCancer Chemotherapy and Pharmacology, 1996
- Cyclosporine And Cremaphor Modulate Von Willebrand Factor Release From Cultured Human Endothelial CellsTransplantation, 1993
- EFFECTS OF CYCLOSPORINE ON CEREBRAL BLOOD FLOW AND METABOLISM IN DOGS1Transplantation, 1992
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI: Journal of the National Cancer Institute, 1990
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971